www.ascopost.com Open in urlscan Pro
52.173.245.249 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://apiservices.krxd.net/click_tracker/track?kxconfid=r6lktnjvq&kxadvertiserid=1457578&kxcampaignid=8392158&kxplacementid...
Effective URL:
https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced...
Submission: On December 19 via manual (December 19th 2019, 4:20:24 pm UTC) from US

Summary HTTP 87 Redirects Links 10 Behaviour Indicators

Summary

This website contacted 35 IPs in 7 countries across 25 domains to perform 87 HTTP transactions. The main IP is 52.173.245.249, located in Des Moines, United States and belongs to MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US. The main domain is www.ascopost.com.
TLS certificate: Issued by Let's Encrypt Authority X3 on October 30th 2019. Valid for: 3 months.

This is the only time www.ascopost.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 3	151.101.12.175 151.101.12.175	54113 (FASTLY) (FASTLY - Fastly)
30	52.173.245.249 52.173.245.249	8075 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation)
3	2a00:1450:400... 2a00:1450:4001:809::200a	15169 (GOOGLE) (GOOGLE - Google LLC)
2	2001:4de0:ac1... 2001:4de0:ac19::1:b:1b	20446 (HIGHWINDS3) (HIGHWINDS3 - Highwinds Network Group)
1	2001:4de0:ac1... 2001:4de0:ac19::1:b:1a	20446 (HIGHWINDS3) (HIGHWINDS3 - Highwinds Network Group)
1	2a00:1450:400... 2a00:1450:4001:819::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
5	2a00:1450:400... 2a00:1450:4001:81e::2008	15169 (GOOGLE) (GOOGLE - Google LLC)
1	35.190.72.161 35.190.72.161	15169 (GOOGLE) (GOOGLE - Google LLC)
1	52.206.22.209 52.206.22.209	14618 (AMAZON-AES) (AMAZON-AES - Amazon.com)
3	23.210.248.44 23.210.248.44	16625 (AKAMAI-AS) (AKAMAI-AS - Akamai Technologies)
3	216.58.207.66 216.58.207.66	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:808::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:80b::2008	15169 (GOOGLE) (GOOGLE - Google LLC)
1	13.224.196.45 13.224.196.45	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	35.190.74.157 35.190.74.157	15169 (GOOGLE) (GOOGLE - Google LLC)
1	35.190.36.172 35.190.36.172	15169 (GOOGLE) (GOOGLE - Google LLC)
3	2a00:1450:400... 2a00:1450:4001:816::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
2	2a00:1450:400... 2a00:1450:4001:814::200e	15169 (GOOGLE) (GOOGLE - Google LLC)
1	216.58.205.226 216.58.205.226	15169 (GOOGLE) (GOOGLE - Google LLC)
1 1	2a00:1450:400... 2a00:1450:4001:818::2008	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:400c:c00::9d	15169 (GOOGLE) (GOOGLE - Google LLC)
6	2a00:1450:400... 2a00:1450:4001:806::2001	15169 (GOOGLE) (GOOGLE - Google LLC)
1	23.210.250.213 23.210.250.213	16625 (AKAMAI-AS) (AKAMAI-AS - Akamai Technologies)
1	2a00:1450:400... 2a00:1450:4001:817::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:809::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:820::2004	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:824::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
1	54.200.247.129 54.200.247.129	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	147.75.85.25 147.75.85.25	54825 (PACKET) (PACKET - Packet Host)
1	147.75.101.51 147.75.101.51	54825 (PACKET) (PACKET - Packet Host)
1	216.58.205.230 216.58.205.230	15169 (GOOGLE) (GOOGLE - Google LLC)
1	147.75.84.33 147.75.84.33	54825 (PACKET) (PACKET - Packet Host)
2	2a03:2880:f01... 2a03:2880:f01c:800e:face:b00c:0:2	32934 (FACEBOOK) (FACEBOOK - Facebook)
1	35.201.98.64 35.201.98.64	15169 (GOOGLE) (GOOGLE - Google LLC)
2	151.101.112.175 151.101.112.175	54113 (FASTLY) (FASTLY - Fastly)
87	35

3 151.101.12.175 (Frankfurt am Main, Germany) 1 redirects

ASN54113 (FASTLY - Fastly, US)

apiservices.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
cdn.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

30 52.173.245.249 (Des Moines, United States)

ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US)

www.ascopost.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
hspbotdetection.azurewebsites.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:809::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2001:4de0:ac19::1:b:1b (Netherlands)

ASN20446 (HIGHWINDS3 - Highwinds Network Group, Inc., US)

maxcdn.bootstrapcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2001:4de0:ac19::1:b:1a (Netherlands)

ASN20446 (HIGHWINDS3 - Highwinds Network Group, Inc., US)

code.jquery.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:819::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:81e::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.190.72.161 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 161.72.190.35.bc.googleusercontent.com

fqtag.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.206.22.209 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-206-22-209.compute-1.amazonaws.com

www.copyright.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 23.210.248.44 (Netherlands)

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a23-210-248-44.deploy.static.akamaitechnologies.com

s7.addthis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
v1.addthisedge.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 216.58.207.66 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra16s25-in-f2.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:808::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:80b::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

ssl.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.224.196.45 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-13-224-196-45.fra2.r.cloudfront.net

a-84279296.cdn.ns8ds.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.190.74.157 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 157.74.190.35.bc.googleusercontent.com

niftyhospital.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.190.36.172 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 172.36.190.35.bc.googleusercontent.com

cdn.fqtag.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:816::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:814::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 216.58.205.226 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra15s24-in-f2.1e100.net

www.googleadservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:818::2008 (Frankfurt am Main, Germany) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)

ssl.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c00::9d (Brussels, Belgium)

ASN15169 (GOOGLE - Google LLC, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:806::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

tpc.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 23.210.250.213 (Netherlands)

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a23-210-250-213.deploy.static.akamaitechnologies.com

z.moatads.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:817::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:809::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:820::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:824::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.200.247.129 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-54-200-247-129.us-west-2.compute.amazonaws.com

a-84279296.ns8ds.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.85.25 (Parsippany, United States)

ASN54825 (PACKET - Packet Host, Inc., US)
PTR: pkt-ams-k1-9

static.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.101.51 (Central, Hong Kong)

ASN54825 (PACKET - Packet Host, Inc., US)
PTR: pkt-ams-k1-7

script.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 216.58.205.230 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra15s24-in-f230.1e100.net

ad.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.84.33 (Parsippany, United States)

ASN54825 (PACKET - Packet Host, Inc., US)

vars.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a03:2880:f01c:800e:face:b00c:0:2 (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)

graph.facebook.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.201.98.64 (Ascension Island)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 64.98.201.35.bc.googleusercontent.com

coordinatedcoat.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 151.101.112.175 (Frankfurt am Main, Germany)

ASN54113 (FASTLY - Fastly, US)

consumer.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
23	ascopost.com www.ascopost.com	219 KB
7	azurewebsites.net hspbotdetection.azurewebsites.net	4 KB
6	googlesyndication.com tpc.googlesyndication.com
6	doubleclick.net securepubads.g.doubleclick.net stats.g.doubleclick.net googleads.g.doubleclick.net ad.doubleclick.net	93 KB
5	googletagmanager.com www.googletagmanager.com	78 KB
5	krxd.net 1 redirects apiservices.krxd.net cdn.krxd.net consumer.krxd.net	103 KB
4	google-analytics.com 1 redirects ssl.google-analytics.com www.google-analytics.com	35 KB
3	hotjar.com static.hotjar.com script.hotjar.com vars.hotjar.com	72 KB
3	gstatic.com fonts.gstatic.com	37 KB
3	googleapis.com fonts.googleapis.com	2 KB
2	facebook.com graph.facebook.com	1 KB
2	ns8ds.com a-84279296.cdn.ns8ds.com a-84279296.ns8ds.com	4 KB
2	google.de adservice.google.de www.google.de	700 B
2	addthis.com s7.addthis.com api-public.addthis.com Failed	189 KB
2	fqtag.com fqtag.com cdn.fqtag.com	30 KB
2	googletagservices.com www.googletagservices.com	44 KB
2	bootstrapcdn.com maxcdn.bootstrapcdn.com	15 KB
1	coordinatedcoat.com coordinatedcoat.com	589 B
1	addthisedge.com v1.addthisedge.com	746 B
1	google.com www.google.com	525 B
1	moatads.com z.moatads.com	1 KB
1	googleadservices.com www.googleadservices.com	10 KB
1	niftyhospital.com niftyhospital.com	31 KB
1	copyright.com www.copyright.com	2 KB
1	jquery.com code.jquery.com	33 KB
87	25

	Domain	Requested by
23	www.ascopost.com	www.ascopost.com
7	hspbotdetection.azurewebsites.net	www.ascopost.com code.jquery.com
6	tpc.googlesyndication.com	securepubads.g.doubleclick.net niftyhospital.com
5	www.googletagmanager.com	www.ascopost.com
3	fonts.gstatic.com	www.ascopost.com
3	securepubads.g.doubleclick.net	www.googletagservices.com securepubads.g.doubleclick.net
3	fonts.googleapis.com	www.ascopost.com
2	consumer.krxd.net	cdn.krxd.net
2	graph.facebook.com	s7.addthis.com
2	www.google-analytics.com	www.googletagmanager.com www.ascopost.com
2	ssl.google-analytics.com	1 redirects www.ascopost.com
2	cdn.krxd.net	www.ascopost.com cdn.krxd.net
2	s7.addthis.com	www.ascopost.com s7.addthis.com
2	www.googletagservices.com	www.ascopost.com securepubads.g.doubleclick.net
2	maxcdn.bootstrapcdn.com	www.ascopost.com
1	coordinatedcoat.com	niftyhospital.com
1	vars.hotjar.com	static.hotjar.com
1	ad.doubleclick.net	niftyhospital.com
1	script.hotjar.com	static.hotjar.com
1	v1.addthisedge.com	s7.addthis.com
1	static.hotjar.com	www.ascopost.com
1	a-84279296.ns8ds.com	www.ascopost.com
1	www.google.de	www.ascopost.com
1	www.google.com	www.ascopost.com
1	googleads.g.doubleclick.net	www.googleadservices.com
1	z.moatads.com	s7.addthis.com
1	stats.g.doubleclick.net	www.ascopost.com
1	www.googleadservices.com	www.googletagmanager.com
1	cdn.fqtag.com	fqtag.com
1	niftyhospital.com	www.ascopost.com
1	a-84279296.cdn.ns8ds.com	www.ascopost.com
1	adservice.google.de	www.googletagservices.com
1	www.copyright.com	www.ascopost.com
1	fqtag.com	www.ascopost.com
1	code.jquery.com	www.ascopost.com
1	apiservices.krxd.net	1 redirects
0	api-public.addthis.com Failed	s7.addthis.com
87	37

This site contains links to these domains. Also see Links.

Domain
educate.ascopost.com
www.copyright.com
www.thelancet.com
www.nejm.org
www.bartscancer.london
hbside.com
www.asco.org
www.addthis.com

Subject Issuer	Validity	Valid
ascopost.com Let's Encrypt Authority X3	`2019-10-30` - `2020-01-28`	3 months	crt.sh
*.storage.googleapis.com GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
*.bootstrapcdn.com Sectigo RSA Domain Validation Secure Server CA	`2019-09-14` - `2020-10-13`	a year	crt.sh
jquery.org COMODO RSA Domain Validation Secure Server CA	`2018-10-17` - `2020-10-16`	2 years	crt.sh
*.azurewebsites.net Microsoft IT TLS CA 5	`2019-09-24` - `2021-09-24`	2 years	crt.sh
*.g.doubleclick.net GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
*.google-analytics.com GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
*.fqtag.com Let's Encrypt Authority X3	`2019-10-15` - `2020-01-13`	3 months	crt.sh
*.copyright.com Go Daddy Secure Certificate Authority - G2	`2018-09-04` - `2020-09-11`	2 years	crt.sh
odc-prod-01.oracle.com DigiCert SHA2 Secure Server CA	`2019-10-10` - `2020-09-04`	a year	crt.sh
*.google.com GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
*.c.ssl.fastly.net GlobalSign CloudSSL CA - SHA256 - G3	`2019-08-23` - `2020-08-23`	a year	crt.sh
*.cdn.ns8ds.com Amazon	`2019-07-28` - `2020-08-28`	a year	crt.sh
niftyhospital.com Let's Encrypt Authority X3	`2019-12-01` - `2020-02-29`	3 months	crt.sh
tpc.googlesyndication.com GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
moatads.com DigiCert ECC Secure Server CA	`2018-11-10` - `2020-02-09`	a year	crt.sh
www.google.com GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
www.google.de GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
gatorapi.com Amazon	`2019-10-05` - `2020-11-05`	a year	crt.sh
static.hotjar.com Let's Encrypt Authority X3	`2019-12-05` - `2020-03-04`	3 months	crt.sh
script.hotjar.com Let's Encrypt Authority X3	`2019-12-05` - `2020-03-04`	3 months	crt.sh
*.doubleclick.net GTS CA 1O1	`2019-12-03` - `2020-02-25`	3 months	crt.sh
vars.hotjar.com Let's Encrypt Authority X3	`2019-12-05` - `2020-03-04`	3 months	crt.sh
*.facebook.com DigiCert SHA2 High Assurance Server CA	`2019-12-06` - `2020-03-05`	3 months	crt.sh
coordinatedcoat.com Let's Encrypt Authority X3	`2019-10-29` - `2020-01-27`	3 months	crt.sh

This page contains 7 frames:

Primary Page: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Frame ID: E39ED0B8873D4C997C6469F267543639
Requests: 85 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 71C97956827F78A67BA09B73112995AE
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: C24C38452121DF3C09D3552A6C493497
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 8CFC110006726E9AD09D08C124F60A4C
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 39B9E50F17B48544E968DA65C3E4421C
Requests: 1 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-b736908ce6b0e933fad3a2e45df61b38.html
Frame ID: 1BC6F8C0412BD6F364B8A1B992018A7B
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-23/html/container.html
Frame ID: 2BE10BB3F5A3C5BF33F14450B84C8540
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page URL History Show full URLs

https://apiservices.krxd.net/click_tracker/track?kxconfid=r6lktnjvq&kxadvertiserid=1457578&kxcampaignid=8... HTTP 302
https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-pa... Page URL

Detected technologies

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

html /<link[^>]+?href="[^"]*bootstrap(?:\.min)?\.css/i

DoubleClick for Publishers (DFP) (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

html /<link[^>]* href=[^>]+(?:([\d.]+)\/)?(?:css\/)?font-awesome(?:\.min)?\.css/i

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Google Font API (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

html /<link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com/i

Lightbox (JavaScript Libraries) Expand

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

script /jquery[.-]([\d.]*\d)[^\/]*\.js/i
script /jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?/i

Page Statistics

87
Requests

98 %
HTTPS

49 %
IPv6

25
Domains

37
Subdomains

35
IPs

7
Countries

1006 kB
Transfer

2848 kB
Size

0
Cookies

10 Outgoing links

These are links going to different origins than the main page.

URL: https://educate.ascopost.com/2018/podcasts/biomarkers-in-immunotherapy/
Title: Biomarkers in Immunotherapy

Search URL Search Domain Scan URL

URL: http://educate.ascopost.com/2018/NSCLC
Title: IMPROVING NSCLC OUTCOMES

Search URL Search Domain Scan URL

URL: http://educate.ascopost.com/2018/AKI
Title: Methotrexate–Induced Kidney Injury

Search URL Search Domain Scan URL

URL: http://www.copyright.com/ccc/openurl.do?issn=2154-3283&WT.mc.id=Harborside%20Press,%20LLC
Title:

Search URL Search Domain Scan URL

URL: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30689-8/fulltext
Title: The Lancet Oncology

Search URL Search Domain Scan URL

URL: https://www.nejm.org/doi/10.1056/NEJMoa1809615
Title: Results of the final progression-free survival analysis

Search URL Search Domain Scan URL

URL: https://www.bartscancer.london/
Title: Barts Cancer Institute, Queen Mary University of London

Search URL Search Domain Scan URL

URL: http://hbside.com/

Search URL Search Domain Scan URL

URL: https://www.asco.org/
Title: ASCO.org

Search URL Search Domain Scan URL

URL: https://www.addthis.com/website-tools/overview?utm_source=AddThis%20Tools&utm_medium=image
Title: AddThis

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://apiservices.krxd.net/click_tracker/track?kxconfid=r6lktnjvq&kxadvertiserid=1457578&kxcampaignid=8392158&kxplacementid=TAPEN-2019-1217&clk=https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c HTTP 302
https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 54

https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=1738555679&utmhn=www.ascopost.com&utmcs=UTF-8&utmsr=1600x1200&utmvp=1585x1185&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=Second%20OS%20Analysis%20of%20First-Line%20Atezolizumab%20Plus%20Nab-paclitaxel%20in%20Advanced%20Triple-Negative%20Breast%20Cancer%20-%20The%20ASCO%20Post&utmhid=1077610759&utmr=-&utmp=%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%252520Evening%252520News%252520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%252520Evening%252520News%252520Emails%2525209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&utmht=1576772393592&utmac=UA-19241164-1&utmcc=__utma%3D141232162.675339317.1576772394.1576772394.1576772394.1%3B%2B__utmz%3D141232162.1576772394.1.1.utmcsr%3DTAP%2520Evening%2520News%2520Emails%7Cutmccn%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%7Cutmcmd%3DEmail%3B&utmjid=931294375&utmredir=1&utmu=qAAAAAAAAAAAAAAAAAAAAAAE~ HTTP 302
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-19241164-1&cid=675339317.1576772394&jid=931294375&_v=5.7.2&z=1738555679

87 HTTP transactions
4 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H/1.1

200
OK

Primary Request

Cookie set / Show response
www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/
Redirect Chain

https://apiservices.krxd.net/click_tracker/track?kxconfid=r6lktnjvq&kxadvertiserid=1457578&kxcampaignid=8392158&kxplacementid=TAPEN-2019-1217&clk=https://www.ascopost.com/news/december-2019/second-...
https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm...

46 KB
19 KB

637ms
218ms

Document
text/html

52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

6bb26b05f6880ff0a235dba87be14659a176847003d91680a89bc69eba3daef1

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Host: www.ascopost.com
Connection: keep-alive
Pragma: no-cache
Cache-Control: no-cache
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-User: ?1
Accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site: none
Sec-Fetch-Mode: navigate
Accept-Encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-User: ?1

Response headers

Cache-Control: private
Content-Length: 18564
Content-Type: text/html; charset=utf-8
Content-Encoding: gzip
Vary: Accept-Encoding
Set-Cookie: ASP.NET_SessionId=4ufz5m0i4rvrgkddxvpq2vn5; path=/; HttpOnly TAPUser=b97e16e4-4f4e-4fa2-8032-339a35452b78; expires=Sat, 19-Dec-2020 16:19:49 GMT; path=/
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7
X-Frame-Options: sameorigin
Date: Thu, 19 Dec 2019 16:19:49 GMT

Redirect headers

Location: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP Evening News Emails&utm_medium=Email&utm_campaign=TAP Evening News Emails 9.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Age: 0 0
Via: 1.1 varnish (Varnish/5.2) 1.1 varnish
Accept-Ranges: bytes bytes
Content-Length: 0
Date: Thu, 19 Dec 2019 16:19:49 GMT
Connection: keep-alive
X-Served-By: click-tracker-main009-ash-prod.krxd.net, cache-fra19149-FRA
X-Cache: MISS, MISS
X-Cache-Hits: 0, 0
X-Timer: S1576772389.219885,VS0,VE95

GET
H/1.1 200
OK bootstrap.css
www.ascopost.com/css/ 132 KB
20 KB 254ms
149ms Stylesheet
text/css 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/css/bootstrap.css

Requested by

Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

0c8af99aed5e34f5b5aac77c3471050a2c9bd5db726d5e28d65020e29bd5b59e

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:49 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 04:41:14 GMT
X-Frame-Options: sameorigin
ETag: "0d1c2886d0d31:0"
Vary: Accept-Encoding
Content-Type: text/css
Accept-Ranges: bytes
Content-Length: 20570
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 css
fonts.googleapis.com/ 16 KB
909 B 59ms
50ms Stylesheet
text/css 2a00:1450:4001:809::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Roboto+Condensed:400,400italic,700,700italic,900,900italic,700,500italic,500,400italic,300italic,300

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

03316767b129ac894080ec893ec9641b190307735654cc66cc97a1d339d8379f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Thu, 19 Dec 2019 16:19:50 GMT
server: ESF
access-control-allow-origin: *
date: Thu, 19 Dec 2019 16:19:50 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H2 200 css
fonts.googleapis.com/ 8 KB
725 B 59ms
51ms Stylesheet
text/css 2a00:1450:4001:809::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Merriweather:400,400italic,700,700italic

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

84f9849e593d9a1f548a9c268e12373366732ec1df8e3f311213b37510eec0e4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Thu, 19 Dec 2019 16:19:50 GMT
server: ESF
access-control-allow-origin: *
date: Thu, 19 Dec 2019 16:19:50 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H2 200 css
fonts.googleapis.com/ 1 KB
507 B 57ms
49ms Stylesheet
text/css 2a00:1450:4001:809::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Josefin+Sans

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

0531ecb16846ad7de741f8614ade8ad94bd0aa0f2466ea935f65f54a58bf9cae

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Thu, 19 Dec 2019 16:19:50 GMT
server: ESF
access-control-allow-origin: *
date: Thu, 19 Dec 2019 16:19:50 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H2 200 font-awesome.min.css
maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/ 23 KB
5 KB 52ms
44ms Stylesheet
text/css 2001:4de0:ac19::1:b:1b
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4de0:ac19::1:b:1b , Netherlands, ASN20446 (HIGHWINDS3 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: /
Resource Hash: 541ac58217a8ade1a5e292a65a0661dc9db7a49ae13654943817a4fbc6761afd

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:50 GMT
content-encoding: gzip
last-modified: Wed, 12 Dec 2018 18:35:19 GMT
access-control-allow-origin: *
etag: "1544639719"
vary: Accept-Encoding
x-cache: HIT
content-type: text/css; charset=utf-8
status: 200
cache-control: public, max-age=31536000
x-hello-human: Say hello back! @getBootstrapCDN on Twitter
accept-ranges: bytes
timing-allow-origin: *
content-length: 5442

GET
H/1.1 200
OK TAP.min.css
www.ascopost.com/css/ 35 KB
6 KB 390ms
128ms Stylesheet
text/css 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/css/TAP.min.css

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

7e6c73ddddd5427aa1a4e5bd19d74ff7889bdc400f9b040b0aaa63e99f1893be

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Tue, 27 Aug 2019 20:04:41 GMT
X-Frame-Options: sameorigin
ETag: "801264a9125dd51:0"
Vary: Accept-Encoding
Content-Type: text/css
Accept-Ranges: bytes
Content-Length: 6235
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK contact-buttons.min.css
www.ascopost.com/css/ 1 KB
968 B 392ms
126ms Stylesheet
text/css 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/css/contact-buttons.min.css

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

fac885de2ddbacbba047917eddedbd323d41cd4c2165f578f5a9363136a0023a

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 04:41:14 GMT
X-Frame-Options: sameorigin
ETag: "23a9a12886d0d31:0"
Vary: Accept-Encoding
Content-Type: text/css
Accept-Ranges: bytes
Content-Length: 628
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK lightbox.css
www.ascopost.com/css/ 4 KB
1 KB 556ms
154ms Stylesheet
text/css 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/css/lightbox.css

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

97969e7b2498cb1e6efd3312ce3c944a134aced7f730f700ac5efcdbc13e44e7

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 04:41:15 GMT
X-Frame-Options: sameorigin
ETag: "8067a52886d0d31:0"
Vary: Accept-Encoding
Content-Type: text/css
Accept-Ranges: bytes
Content-Length: 1016
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK jquery-1.12.4.min.js Show response
code.jquery.com/ 95 KB
33 KB 197ms
94ms Script
application/javascript 2001:4de0:ac19::1:b:1a
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://code.jquery.com/jquery-1.12.4.min.js
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2001:4de0:ac19::1:b:1a , Netherlands, ASN20446 (HIGHWINDS3 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: nginx /
Resource Hash: 668b046d12db350ccba6728890476b3efee53b2f42dbb84743e5e9f1ae0cc404

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Fri, 20 May 2016 17:18:54 GMT
Server: nginx
ETag: W/"573f46fe-17b8b"
Vary: Accept-Encoding
X-HW: 1576772390.dop126.fr8.shc,1576772390.dop126.fr8.t,1576772390.cds010.fr8.c
Content-Type: application/javascript; charset=utf-8
Access-Control-Allow-Origin: *
Cache-Control: max-age=315360000, public
Connection: Keep-Alive
Accept-Ranges: bytes
Content-Length: 33738

GET
H/1.1 200
OK HSP.js Show response
hspbotdetection.azurewebsites.net/ 3 KB
2 KB 619ms
131ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/HSP.js
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: 5d664500cbb75fb91cedc153413e0b1fa095c2ac7683a01bb807946b90b7aab8

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:49 GMT
Content-Encoding: gzip
Last-Modified: Thu, 12 Dec 2019 18:26:07 GMT
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
ETag: "8089929e19b1d51:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 1107

GET
H2 200 gpt.js Show response
www.googletagservices.com/tag/js/ 51 KB
16 KB 51ms
45ms Script
text/javascript 2a00:1450:4001:819::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:819::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

f213be31d540e30366635b474daedd9c0b46287d55429ec9ef7a4829361c6f01

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:50 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "371 / 494 of 1000 / last-modified: 1576520981"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 15827
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H/1.1 200
OK showads.js Show response
www.ascopost.com/scripts/ 21 B
492 B 559ms
158ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/showads.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

abd9155ac0fe0e62fdb9e2c1c333357cd33107972a57eff5224b0f3d0d2df316

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:11:00 GMT
X-Frame-Options: sameorigin
ETag: "c748db292d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 137
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 73 KB
27 KB 53ms
48ms Script
application/javascript 2a00:1450:4001:81e::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=UA-15871495-32

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

7ca12e6c3b5bbf44503f8e6ba649deef2ae8a7904eb3e8eb602dbec975caa770

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:50 GMT
content-encoding: br
last-modified: Thu, 19 Dec 2019 15:00:00 GMT
server: Google Tag Manager
access-control-allow-origin: http://www.googletagmanager.com
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
content-length: 27814
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 73 KB
27 KB 53ms
48ms Script
application/javascript 2a00:1450:4001:81e::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-995132428

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

8758ac11bbb11520feb653be4b23669dbd2b544105d77c7941c456eddf802948

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:50 GMT
content-encoding: br
last-modified: Thu, 19 Dec 2019 15:00:00 GMT
server: Google Tag Manager
access-control-allow-origin: http://www.googletagmanager.com
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
content-length: 27814
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:50 GMT

GET
H2 200 implement-r.js Show response
fqtag.com/tag/ 1 KB
2 KB 99ms
24ms Script
application/javascript 35.190.72.161
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fqtag.com/tag/implement-r.js?org=BvKonlk6Tpo1GnpIj1nN&s=%3C%=HttpContext.Current.Session.SessionID%%3E&p=ascopost&a=%3C%=strUTMSource&cmp%%3E%3C/script%3E%3C%=strUTMCampaign%%3E&fmt=banner&rd=%3C%=strReferrer%%3E&rt=display

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

35.190.72.161 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

161.72.190.35.bc.googleusercontent.com

Software

Resource Hash

7d9aa52a52984bd5fcefdaea3210f26c20dd1c8635485c0bfea37743b1d538e6

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:50 GMT
via: 1.1 google
access-control-allow-origin: *
content-type: application/javascript
status: 200
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 1495
x-xss-protection: 0
expires: 0

GET
H/1.1 200
OK tap-wt-logo_2017.svg
www.ascopost.com/media/14006457/ 3 KB
2 KB 475ms
155ms Image
image/svg+xml 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14006457/tap-wt-logo_2017.svg

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

1fba3679602e0a917e3998562a5fd335b73c4522c7cfb9076b70aa0bf823ac0b

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:49 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 08:11:10 GMT
X-Frame-Options: sameorigin
ETag: "0e3d97ba3d0d31:0"
Vary: Accept-Encoding
Content-Type: image/svg+xml
Accept-Ranges: bytes
Content-Length: 1525
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 get-permission-btn-big.png
www.copyright.com/wp-content/themes/copyrightclearancecenter/img/link-generator/ 1 KB
2 KB 3507ms
141ms Image
image/png 52.206.22.209
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.copyright.com/wp-content/themes/copyrightclearancecenter/img/link-generator/get-permission-btn-big.png
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.206.22.209 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-206-22-209.compute-1.amazonaws.com
Software: Apache /
Resource Hash: 57d853ebb82e990e3845e6590058a06020686f89de88110dc21926aca6287aa0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:56 GMT
last-modified: Thu, 18 Feb 2016 20:22:58 GMT
server: Apache
etag: "5c7-52c1121e0cc80"
content-type: image/png
status: 200
accept-ranges: bytes
content-length: 1479

GET
H/1.1 200
OK 6_schmid.jpg
www.ascopost.com/media/14011254/ 16 KB
16 KB 16743ms
205ms Image
image/jpeg 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14011254/6_schmid.jpg

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

a751f48498fefd59cd29e8821c014c3f5d3a1bd4c8aec424fce942b9d7d8b3b2

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Fri, 25 Oct 2019 13:28:54 GMT
ETag: "3bd5c525388bd51:0"
X-Frame-Options: sameorigin
Content-Type: image/jpeg
Accept-Ranges: bytes
Content-Length: 16196
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK banner_ad-tap_kidneyce-320x50-mobile.gif
www.ascopost.com/media/14008262/ 84 KB
84 KB 16689ms
126ms Image
image/gif 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14008262/banner_ad-tap_kidneyce-320x50-mobile.gif

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

d54408be91f7d1ac8d4465f51619df6bb8e8d600f0ada79d459bc461c4c9202c

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Thu, 07 Jun 2018 15:45:18 GMT
ETag: "4161418976fed31:0"
X-Frame-Options: sameorigin
Content-Type: image/gif
Accept-Ranges: bytes
Content-Length: 86012
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK banner_tap-ce_nsclc_320x50.gif
www.ascopost.com/media/14009054/ 18 KB
18 KB 16871ms
127ms Image
image/gif 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14009054/banner_tap-ce_nsclc_320x50.gif

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

831e6d01ca98f060d9112c0feb6ccf9bae099422960dc97a8c9dfdac2533edea

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Wed, 14 Nov 2018 17:56:11 GMT
ETag: "c6b81f54437cd41:0"
X-Frame-Options: sameorigin
Content-Type: image/gif
Accept-Ranges: bytes
Content-Length: 18612
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK video_play_btn_teal.png
www.ascopost.com/media/14009053/ 3 KB
4 KB 1560ms
131ms Image
image/png 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14009053/video_play_btn_teal.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

6fcfa885ea2944d968bb310338e17fbf50f716cb093b397bfe5ca3d9630a5aff

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Wed, 14 Nov 2018 17:10:10 GMT
ETag: "3e135be63c7cd41:0"
X-Frame-Options: sameorigin
Content-Type: image/png
Accept-Ranges: bytes
Content-Length: 3534
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK logo_hbside_300w.png
www.ascopost.com/media/14007769/ 6 KB
7 KB 1584ms
126ms Image
image/png 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14007769/logo_hbside_300w.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

0f3e4376d3061e4fe79ff308bcfb994747f07942a5f4d4aae3a1a8894ae1fa75

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Tue, 10 Apr 2018 08:20:13 GMT
ETag: "1266c0a4d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/png
Accept-Ranges: bytes
Content-Length: 6485
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK showup.js Show response
www.ascopost.com/scripts/ 2 KB
1 KB 296ms
158ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/showup.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

484873074b4005d7fa78f4e69668e3a468300588e97b9f91b412f58f859e9bf0

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:49 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:11:00 GMT
X-Frame-Options: sameorigin
ETag: "7cefb7b292d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 873
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 bootstrap.min.js Show response
maxcdn.bootstrapcdn.com/bootstrap/3.3.6/js/ 36 KB
10 KB 489ms
202ms Script
text/javascript 2001:4de0:ac19::1:b:1b
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/js/bootstrap.min.js
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4de0:ac19::1:b:1b , Netherlands, ASN20446 (HIGHWINDS3 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: /
Resource Hash: 2979f9a6e32fc42c3e7406339ee9fe76b31d1b52059776a02b4a7fa6a4fd280a

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com

Response headers

date: Thu, 19 Dec 2019 16:19:51 GMT
content-encoding: gzip
last-modified: Wed, 12 Dec 2018 18:33:51 GMT
access-control-allow-origin: *
etag: "1544639631"
vary: Accept-Encoding
x-cache: HIT
content-type: text/javascript; charset=utf-8
status: 200
cache-control: public, max-age=31536000
x-hello-human: Say hello back! @getBootstrapCDN on Twitter
accept-ranges: bytes
timing-allow-origin: *
content-length: 9764

GET
H/1.1 200
OK jquery.contact-buttons.min.js Show response
www.ascopost.com/scripts/ 2 KB
1 KB 134ms
130ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/jquery.contact-buttons.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

74bdfaf616519b6645a6c52aabbdc400c89255cd00f2344a5c2e22d54135c833

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:50 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:10:59 GMT
X-Frame-Options: sameorigin
ETag: "45c728b292d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 1140
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 addthis_widget.js Show response
s7.addthis.com/js/300/ 349 KB
113 KB 148ms
39ms Script
application/javascript 23.210.248.44
Akamai Technologies

General

Check archive.org

Show headers Download Go to

Full URL

https://s7.addthis.com/js/300/addthis_widget.js

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

23.210.248.44 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),

Reverse DNS

a23-210-248-44.deploy.static.akamaitechnologies.com

Software

nginx/1.15.8 /

Resource Hash

7c20e3e201e3d7c6821e907def1257deb544eb08578c7129b96d53bbf62d34e4

Security Headers

Name	Value
Strict-Transport-Security	max-age=15724800; includeSubDomains

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=15724800; includeSubDomains
content-encoding: gzip
last-modified: Wed, 30 Oct 2019 19:35:04 GMT
server: nginx/1.15.8
etag: "5db9e5e8-57446"
vary: Accept-Encoding
x-distribution: 99
content-type: application/javascript
status: 200
cache-control: public, max-age=600
date: Thu, 19 Dec 2019 16:19:53 GMT
x-host: s7.addthis.com
content-length: 114924

GET
H/1.1 200
OK classie.min.js Show response
www.ascopost.com/scripts/ 953 B
858 B 16702ms
138ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/classie.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

9fcf6e81855ee4237164204143f47a4dcc9132a0105a11f3bb1b570367d3f78f

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:10:58 GMT
X-Frame-Options: sameorigin
ETag: "de2eafb192d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 502
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK lightbox.min.js Show response
www.ascopost.com/scripts/ 10 KB
3 KB 16540ms
125ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/lightbox.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

3ab0c360674dc50bb9b607dae679177d7d9d4cc914e96218383f5154f81ad242

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:10:59 GMT
X-Frame-Options: sameorigin
ETag: "809bc2b192d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 2770
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK inline-tweet.min.js Show response
www.ascopost.com/scripts/ 3 KB
2 KB 16564ms
128ms Script
application/x-javascript 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/scripts/inline-tweet.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

32f9b734c730b3f147b461c0d74681b52fa94cf8e6cb4335c02844638c913072

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Content-Encoding: gzip
Last-Modified: Tue, 10 Apr 2018 06:10:59 GMT
X-Frame-Options: sameorigin
ETag: "809bc2b192d0d31:0"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Accept-Ranges: bytes
Content-Length: 1422
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

OPTIONS
H/1.1 200
OK Analyze Show response
hspbotdetection.azurewebsites.net/AnalyzeTraffic.aspx/ 0
321 B 521ms
128ms XHR
text/plain 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/AnalyzeTraffic.aspx/Analyze
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: / ASP.NET
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Access-Control-Request-Method: POST
Origin: https://www.ascopost.com
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Access-Control-Request-Headers: content-type

Response headers

Access-Control-Allow-Origin: *
Date: Thu, 19 Dec 2019 16:19:50 GMT
Access-Control-Allow-Headers: content-type
X-Powered-By: ASP.NET
Content-Length: 0

POST
H/1.1 200
OK Analyze Show response
hspbotdetection.azurewebsites.net/AnalyzeTraffic.aspx/ 7 B
632 B 984ms
983ms XHR
application/json 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/AnalyzeTraffic.aspx/Analyze
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: 99e6326a5a58748fb618850ce96523d192332126fbaeafd073b004f75148fdd3

Request headers

Accept: */*
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: application/json; charset=utf-8

Response headers

Date: Thu, 19 Dec 2019 16:19:51 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/json; charset=utf-8
Access-Control-Allow-Origin: *
Cache-Control: private, max-age=0
Content-Length: 128
Request-Context: appId=cid-v1:bc6b0b25-bf9c-4488-ba1b-7bea22bb777c

OPTIONS
H/1.1 200
OK Gator Show response
hspbotdetection.azurewebsites.net/GatorBot.aspx/ 0
321 B 128ms
128ms XHR
text/plain 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/GatorBot.aspx/Gator
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: / ASP.NET
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Access-Control-Request-Method: POST
Origin: https://www.ascopost.com
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Access-Control-Request-Headers: content-type

Response headers

Access-Control-Allow-Origin: *
Date: Thu, 19 Dec 2019 16:19:51 GMT
Access-Control-Allow-Headers: content-type
X-Powered-By: ASP.NET
Content-Length: 0

POST
H/1.1 200
OK Gator Show response
hspbotdetection.azurewebsites.net/GatorBot.aspx/ 9 B
635 B 238ms
238ms XHR
application/json 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/GatorBot.aspx/Gator
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: f4836a94818e6c30ba915d59cfa788288687e9afd63726ffc2e45122b9beddb2

Request headers

Accept: */*
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: application/json; charset=utf-8

Response headers

Date: Thu, 19 Dec 2019 16:19:52 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/json; charset=utf-8
Access-Control-Allow-Origin: *
Cache-Control: private, max-age=0
Content-Length: 131
Request-Context: appId=cid-v1:bc6b0b25-bf9c-4488-ba1b-7bea22bb777c

OPTIONS
H/1.1 200
OK AnalyzeUA Show response
hspbotdetection.azurewebsites.net/AnalyzeUA.aspx/ 0
321 B 133ms
131ms XHR
text/plain 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/AnalyzeUA.aspx/AnalyzeUA
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: / ASP.NET
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Access-Control-Request-Method: POST
Origin: https://www.ascopost.com
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Access-Control-Request-Headers: content-type

Response headers

Access-Control-Allow-Origin: *
Date: Thu, 19 Dec 2019 16:19:52 GMT
Access-Control-Allow-Headers: content-type
X-Powered-By: ASP.NET
Content-Length: 0

POST
H/1.1 200
OK AnalyzeUA Show response
hspbotdetection.azurewebsites.net/AnalyzeUA.aspx/ 7 B
632 B 144ms
136ms XHR
application/json 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL: https://hspbotdetection.azurewebsites.net/AnalyzeUA.aspx/AnalyzeUA
Requested by: Host: code.jquery.com
URL: https://code.jquery.com/jquery-1.12.4.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: b852cecdbbaa3d079fbbf5c5492ca3fad1d05cdb620033a75b60365b700000ac

Request headers

Accept: */*
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: application/json; charset=utf-8

Response headers

Date: Thu, 19 Dec 2019 16:19:52 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/json; charset=utf-8
Access-Control-Allow-Origin: *
Cache-Control: private, max-age=0
Content-Length: 128
Request-Context: appId=cid-v1:bc6b0b25-bf9c-4488-ba1b-7bea22bb777c

GET
H2 200 pubads_impl_2019121002.js Show response
securepubads.g.doubleclick.net/gpt/ 163 KB
60 KB 90ms
34ms Script
text/javascript 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019121002.js

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

sffe /

Resource Hash

216fd62bccc74ef4e4d35292cd4874e7072a4fb30685afb6235d894a3ec1a2df

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Intervention: <https://www.chromestatus.com/feature/5718547946799104>; level="warning"

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 10 Dec 2019 17:29:18 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 60922
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:53 GMT

GET
H2 200 integrator.sync.js Show response
adservice.google.de/adsid/ 113 B
175 B 74ms
0ms Script
application/javascript 2a00:1450:4001:808::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.sync.js?domain=www.ascopost.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ea03bfd7fdda1eac185ebc3e8e74b33065b04c8e0adc48cbbd4136748dbd2742

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-type: application/javascript; charset=UTF-8
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 108
x-xss-protection: 0

GET
H/1.1 200
OK r3w55wq40.js Show response
cdn.krxd.net/controltag/ 64 KB
22 KB 23322ms
26ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.krxd.net/controltag/r3w55wq40.js
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 5a509192dabd93107765367434c1f54bca0666f0f80b058f3c40b8e7dc2f4037

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

X-CDN-Backend: 4FrRTvEr9h480D4BywjehZ--F_config_service_ash_prod
Date: Thu, 19 Dec 2019 16:20:16 GMT
Via: 1.1 varnish, 1.1 varnish
Age: 842
X-Cache: MISS, HIT, HIT
X-App-Cache: HIT
Connection: keep-alive
Content-Encoding: gzip
Content-Length: 21453
X-Served-By: config-service-a003-ash-prod.krxd.net, cache-iad2149-IAD, cache-fra19121-FRA
X-Response-Time: 0
X-Do-Esi: esi
X-Timer: S1576772417.567884,VS0,VE1
ETag: "b155c5f0c00c4648021e510afcefc886d6bacab3"
Vary: Accept-Encoding
Content-Type: text/javascript; charset=utf-8
Cache-Control: public, max-age=1200
Accept-Ranges: bytes
X-Age: 0
X-Cache-Hits: 0, 3, 1

GET
H2 200 ga.js Show response
ssl.google-analytics.com/ 45 KB
17 KB 14ms
6ms Script
text/javascript 2a00:1450:4001:80b::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://ssl.google-analytics.com/ga.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

1259ea99bd76596239bfd3102c679eb0a5052578dc526b0452f4d42f8bcdd45f

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 17:22:41 GMT
server: Golfe2
age: 6350
date: Thu, 19 Dec 2019 14:34:03 GMT
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=7200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 17168
expires: Thu, 19 Dec 2019 16:34:03 GMT

GET
H2 200 web Show response
a-84279296.cdn.ns8ds.com/ 10 KB
4 KB 15446ms
43ms Script
application/javascript 13.224.196.45
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://a-84279296.cdn.ns8ds.com/web?t=437992
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 13.224.196.45 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: server-13-224-196-45.fra2.r.cloudfront.net
Software: NS8.com API /
Resource Hash: d1f6d1da2c687d3b81cdf2ac113fb666c8817ac94dfb7f2eaedd409c0aec7cc8

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 11:17:32 GMT
content-encoding: gzip
content-md5: 3O6d/V9w0WGiuDkMHkF2qw==
age: 17529
x-cache: Hit from cloudfront
status: 200
request-id: 717fe1e4-697f-4a0a-a689-089601254282
via: 1.1 3aed5a4f89d72775aaf2cc5a5f642386.cloudfront.net (CloudFront)
response-time: 0
server: NS8.com API
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: Api-Version, Request-Id, Response-Time
x-amz-cf-pop: FRA2-C1
access-control-allow-headers: Accept, Accept-Version, Content-Length, Content-MD5, Content-Type, Date, Api-Version, Response-Time
x-amz-cf-id: eDk1SBG4rPShyBYhxko_OE-ow6stoqTcbmEDis6Qu5mSEfdtKXm7sg==

GET
H2 200 yraDhuW7iybpSh2SzSy4o7-Y3TkogTm6znho_rsVWeuZBkawP2-PZg76oe2LC2HVxqH Show response
niftyhospital.com/v2/0/ 100 KB
31 KB 1170ms
50ms Script
text/javascript 35.190.74.157
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://niftyhospital.com/v2/0/yraDhuW7iybpSh2SzSy4o7-Y3TkogTm6znho_rsVWeuZBkawP2-PZg76oe2LC2HVxqH

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

35.190.74.157 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

157.74.190.35.bc.googleusercontent.com

Software

Resource Hash

3e34d71c037f6c928ba2645360a8ae0b8955ef40ad4bcd7b3d8b91a7df84f198

Security Headers

Name	Value
Strict-Transport-Security	max-age=15724800; preload

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=15724800; preload
content-encoding: gzip
x-datacenter: gce-europe-west1
etag: e027c429c1fbd61e405698c5e098837b0be5fcb64a234ae43ee76e3cb13abcab
vary: Accept-Encoding
x-hostname: regan
content-type: text/javascript; charset=utf-8
status: 200
cache-control: private, must-revalidate, max-age=21600
date: Thu, 19 Dec 2019 16:19:54 GMT
timing-allow-origin: *

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 67 KB
23 KB 43ms
15ms Script
application/javascript 2a00:1450:4001:81e::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-W56397

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

048e5a2bbde457e829908ce5048b0091131c47c868660e4834f777a81cc1a522

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: br
last-modified: Thu, 19 Dec 2019 15:00:00 GMT
server: Google Tag Manager
access-control-allow-origin: http://www.googletagmanager.com
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
content-length: 23074
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:53 GMT

GET
H2 200 pixel-omid.js Show response
cdn.fqtag.com/1.23.311-035f1ce/ 81 KB
28 KB 331ms
24ms Script
application/javascript 35.190.36.172
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.fqtag.com/1.23.311-035f1ce/pixel-omid.js
Requested by: Host: fqtag.com
URL: https://fqtag.com/tag/implement-r.js?org=BvKonlk6Tpo1GnpIj1nN&s=%3C%=HttpContext.Current.Session.SessionID%%3E&p=ascopost&a=%3C%=strUTMSource&cmp%%3E%3C/script%3E%3C%=strUTMCampaign%%3E&fmt=banner&rd=%3C%=strReferrer%%3E&rt=display
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.190.36.172 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS: 172.36.190.35.bc.googleusercontent.com
Software: UploadServer /
Resource Hash: 8832c2287cdec0e2f4472a910a9b63a2472b0dc8c64ddb7505e92a4ec90b6f3f

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Wed, 20 Nov 2019 09:26:45 GMT
content-encoding: gzip
age: 2530388
status: 200
x-guploader-uploadid: AEnB2UqEgqpjGgTt_1YWLF-w40-F3po6fCnd5Qef9oIFS8E_0huYb5aoycpvu9RBh2VgIW4YLjiPV6cIO1hZRh-N_bbnOAXoeg
x-goog-storage-class: MULTI_REGIONAL
x-goog-metageneration: 1
x-goog-stored-content-encoding: gzip
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 28168
last-modified: Mon, 18 Nov 2019 16:01:06 GMT
server: UploadServer
etag: "a1ebb141cb6a23d31306cb78917553c0"
x-goog-hash: crc32c=uJOA+w==, md5=oeuxQctqI9MTBst4kXVTwA==
content-language: en
x-goog-generation: 1574092866668207
cache-control: public,max-age=31556926,no-transform
x-goog-stored-content-length: 28168
accept-ranges: bytes
content-type: application/javascript
expires: Thu, 19 Nov 2020 09:26:45 GMT

GET
H/1.1 200
OK search-icon.svg
www.ascopost.com/media/14003896/ 784 B
1 KB 16129ms
586ms Image
image/svg+xml 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/media/14003896/search-icon.svg

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

30f96c88f6eb9458190b3562561ba4a964ccc68676eaa38b36b44cab945f0415

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/css/TAP.min.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:08 GMT
Last-Modified: Tue, 10 Apr 2018 07:49:52 GMT
ETag: "a4806982a0d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/svg+xml
Accept-Ranges: bytes
Content-Length: 784
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK close.png
www.ascopost.com/images/ 280 B
573 B 1686ms
125ms Image
image/png 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/images/close.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

5d62e6c90005bfb71f6abb440f9e4753681cb23bbd5e60477ab6f442d2f0e69c

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/css/lightbox.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Tue, 10 Apr 2018 04:41:19 GMT
ETag: "2b7342b86d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/png
Accept-Ranges: bytes
Content-Length: 280
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK loading.gif
www.ascopost.com/images/ 8 KB
9 KB 1710ms
125ms Image
image/gif 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/images/loading.gif

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

225aa88b6ab02c06222ec9468d62e15fa188e39cdb9431d1f55401ad380753ed

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/css/lightbox.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Tue, 10 Apr 2018 04:42:36 GMT
ETag: "35944e5986d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/gif
Accept-Ranges: bytes
Content-Length: 8476
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK prev.png
www.ascopost.com/images/ 1 KB
2 KB 1815ms
126ms Image
image/png 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/images/prev.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

7fd9273f20fdb1229c224341271a119020a5eee74ccf6b4605730917c864caf2

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/css/lightbox.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:10 GMT
Last-Modified: Tue, 10 Apr 2018 04:42:37 GMT
ETag: "bea39f5986d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/png
Accept-Ranges: bytes
Content-Length: 1360
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H/1.1 200
OK next.png
www.ascopost.com/images/ 1 KB
2 KB 1847ms
136ms Image
image/png 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.ascopost.com/images/next.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

15b869b02c6fbaa8c6c26445a2dd2d9bad80fd27b1409f8179e5dd89dc89d90a

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

Referer: https://www.ascopost.com/css/lightbox.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Tue, 10 Apr 2018 04:42:37 GMT
ETag: "d0cc875986d0d31:0"
X-Frame-Options: sameorigin
Content-Type: image/png
Accept-Ranges: bytes
Content-Length: 1350
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2 200 u-440qyriQwlOrhSvowK_l5-fCZMdeX3rg.woff2
fonts.gstatic.com/s/merriweather/v21/ 12 KB
12 KB 27ms
27ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/merriweather/v21/u-440qyriQwlOrhSvowK_l5-fCZMdeX3rg.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

e4fa437e044d3f739bd5e4aa2d1bd94e3952e888baec655763cd7969576001da

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://fonts.googleapis.com/css?family=Merriweather:400,400italic,700,700italic
Origin: https://www.ascopost.com

Response headers

date: Fri, 22 Nov 2019 01:31:18 GMT
x-content-type-options: nosniff
last-modified: Mon, 22 Jul 2019 19:18:46 GMT
server: sffe
age: 2386115
content-type: font/woff2
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
access-control-allow-origin: *
content-length: 12256
x-xss-protection: 0
expires: Sat, 21 Nov 2020 01:31:18 GMT

GET
H2 200 u-4m0qyriQwlOrhSvowK_l5-eRZOf-LVrPHp.woff2
fonts.gstatic.com/s/merriweather/v21/ 12 KB
13 KB 19ms
18ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/merriweather/v21/u-4m0qyriQwlOrhSvowK_l5-eRZOf-LVrPHp.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

75560fc1985882674f53eff22da403b42e7f0bb5c04859041966c2a4718866e4

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://fonts.googleapis.com/css?family=Merriweather:400,400italic,700,700italic
Origin: https://www.ascopost.com

Response headers

date: Thu, 21 Nov 2019 15:21:15 GMT
x-content-type-options: nosniff
last-modified: Mon, 22 Jul 2019 19:19:08 GMT
server: sffe
age: 2422718
content-type: font/woff2
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
access-control-allow-origin: *
content-length: 12700
x-xss-protection: 0
expires: Fri, 20 Nov 2020 15:21:15 GMT

GET
H2 200 u-4n0qyriQwlOrhSvowK_l52xwNZWMf6hPvhPQ.woff2
fonts.gstatic.com/s/merriweather/v21/ 12 KB
12 KB 10ms
9ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/merriweather/v21/u-4n0qyriQwlOrhSvowK_l52xwNZWMf6hPvhPQ.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

b986fbc59b4f9794ff0d1bd475093053df31b2b79b545daf4125f0abf912716b

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://fonts.googleapis.com/css?family=Merriweather:400,400italic,700,700italic
Origin: https://www.ascopost.com

Response headers

date: Thu, 21 Nov 2019 17:11:42 GMT
x-content-type-options: nosniff
last-modified: Mon, 22 Jul 2019 19:18:58 GMT
server: sffe
age: 2416091
content-type: font/woff2
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
access-control-allow-origin: *
content-length: 12192
x-xss-protection: 0
expires: Fri, 20 Nov 2020 17:11:42 GMT

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 43 KB
18 KB 41ms
9ms Script
text/javascript 2a00:1450:4001:814::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-15871495-32

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:814::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 17:22:41 GMT
server: Golfe2
age: 6376
date: Thu, 19 Dec 2019 14:33:37 GMT
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=7200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 17803
expires: Thu, 19 Dec 2019 16:33:37 GMT

GET
H2 200 conversion_async.js Show response
www.googleadservices.com/pagead/ 26 KB
10 KB 44ms
37ms Script
text/javascript 216.58.205.226
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googleadservices.com/pagead/conversion_async.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-15871495-32

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.205.226 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra15s24-in-f2.1e100.net

Software

cafe /

Resource Hash

77ce0ec2a02b410eee12285bd7487b2599970ac39b6ff58c0b748b6e2df36f3c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 9933
x-xss-protection: 0
server: cafe
etag: 9795501548502167919
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=3600
timing-allow-origin: *
expires: Thu, 19 Dec 2019 16:19:53 GMT

GET
H/1.1 200
OK glyphicons-halflings-regular.woff2
www.ascopost.com/fonts/ 18 KB
18 KB 16089ms
851ms Font
application/x-font-woff2 52.173.245.249
Microsoft Corpora...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.ascopost.com/fonts/glyphicons-halflings-regular.woff2

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

52.173.245.249 Des Moines, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US),

Reverse DNS

Software

Resource Hash

fe185d11a49676890d47bb783312a0cda5a44c4039214094e7957b4c040ef11c

Security Headers

Name	Value
X-Frame-Options	sameorigin

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/css/bootstrap.css
Origin: https://www.ascopost.com

Response headers

Date: Thu, 19 Dec 2019 16:20:09 GMT
Last-Modified: Tue, 10 Apr 2018 04:41:18 GMT
ETag: "a46eba2a86d0d31:0"
X-Frame-Options: sameorigin
Content-Type: application/x-font-woff2
Access-Control-Allow-Origin: https://www.ascopost.com
Accept-Ranges: bytes
Content-Length: 18028
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7

GET
H2

200

collect
stats.g.doubleclick.net/r/
Redirect Chain

https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=1738555679&utmhn=www.ascopost.com&utmcs=UTF-8&utmsr=1600x1200&utmvp=1585x1185&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=Sec...
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-19241164-1&cid=675339317.1576772394&jid=931294375&_v=5.7.2&z=1738555679

35 B
407 B

60ms
17ms

Image
image/gif

2a00:1450:400c:c00::9d
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-19241164-1&cid=675339317.1576772394&jid=931294375&_v=5.7.2&z=1738555679

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:400c:c00::9d Brussels, Belgium, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
strict-transport-security: max-age=10886400; includeSubDomains; preload
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
access-control-allow-origin: *
date: Thu, 19 Dec 2019 16:19:53 GMT
content-type: image/gif
status: 200
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 35
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:53 GMT
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
access-control-allow-origin: *
location: https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-19241164-1&cid=675339317.1576772394&jid=931294375&_v=5.7.2&z=1738555679
content-type: text/html; charset=UTF-8
status: 302
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 369
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 18 KB
5 KB 191ms
127ms XHR
text/plain 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2123430594756834&correlator=1018115395913779&output=ldjh&impl=fifs&adsid=NT&eid=21062453%2C21063636%2C21065211&vrg=2019121002&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20191219&iu_parts=56049762%2CTAPv2-728x90%2CTAPv2-300x250&enc_prev_ius=%2F0%2F1%2C%2F0%2F2%2C%2F0%2F2%2C%2F0%2F2&prev_iu_szs=728x90%2C300x250%2C300x250%2C300x250&prev_scp=pos%3Dtopbox%7Cpos%3DrightAd1%7Cpos%3DrightAd2%7Cpos%3DrightAd3&cust_params=ksg%3D%26kuid%3D%26isbot%3D1%26url%3Dnews%252Fdecember-2019%252Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%252F%26domain%3Dascopost.com&cookie_enabled=1&bc=31&abxe=1&lmt=1576772393&dt=1576772393683&dlt=1576772389995&idt=3122&frm=20&biw=1585&bih=1185&oid=3&adxs=429%2C1033%2C1033%2C1033&adys=101%2C241%2C1343%2C545&adks=3999439058%2C2342972705%2C2342972710%2C2342972711&ucis=1%7C2%7C3%7C4&ifi=1&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&dssz=37&icsg=43776&std=0&csl=997&vis=1&dmc=8&scr_x=0&scr_y=0&psz=730x107%7C302x252%7C302x252%7C302x252&msz=730x92%7C300x-1%7C300x-1%7C300x-1&ga_vid=675339317.1576772394&ga_sid=1576772394&ga_hid=1077610759&ga_fc=true&fws=0%2C0%2C0%2C0&ohw=0%2C0%2C0%2C0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

cafe /

Resource Hash

b91ddc81df5ac34b5711ce138165510312509fa2bc9c829d01ddaa41fc48658b

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2,-2,-2,-2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 5067
x-xss-protection: 0
google-lineitem-id: 4898626942,4898626942,4898626942,5240620947
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138250318224,138250318218,138250317879,138297121594
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.ascopost.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 pubads_impl_rendering_2019121002.js Show response
securepubads.g.doubleclick.net/gpt/ 64 KB
25 KB 99ms
38ms Script
text/javascript 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019121002.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

sffe /

Resource Hash

4c52ed8f9039265ffed7fdca0b967b2624325e6356433f437e044b0dd332cddf

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 10 Dec 2019 17:29:18 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 24811
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:53 GMT

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ 0
0 38ms
6ms Other
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019121002.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software: /
Resource Hash

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

GET
H/1.1 200
OK moatframe.js Show response
z.moatads.com/addthismoatframe568911941483/ 2 KB
1 KB 91ms
26ms Script
application/x-javascript 23.210.250.213
Akamai Technologies

General

Check archive.org

Show headers Download Go to

Full URL: https://z.moatads.com/addthismoatframe568911941483/moatframe.js
Requested by: Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 23.210.250.213 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS: a23-210-250-213.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: 05090f9390f5bc0cd23fe5f432037cc92d7cbce1ced9bfe8faf3d1c9abae85cd

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:19:53 GMT
Content-Encoding: gzip
Last-Modified: Fri, 08 Nov 2019 20:13:52 GMT
Server: AmazonS3
x-amz-request-id: FBAF69B7861DE212
ETag: "f14b4e1f799b14f798a195f43cf58376"
Vary: Accept-Encoding
Content-Type: application/x-javascript
Cache-Control: max-age=48784
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 948
x-amz-id-2: mINJDBnKUfP83RzDJ6hQaYSGPvMPOM770jd+gXVSD8LFScfPdVPaVzI4W2IwmrtEKhDna93Nv9A=

GET
H2 200 collect
www.google-analytics.com/r/ 35 B
199 B 22ms
21ms Image
image/gif 2a00:1450:4001:814::200e
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1077610759&t=pageview&_s=1&dl=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&ul=en-us&de=UTF-8&dt=Second%20OS%20Analysis%20of%20First-Line%20Atezolizumab%20Plus%20Nab-paclitaxel%20in%20Advanced%20Triple-Negative%20Breast%20Cancer%20-%20The%20ASCO%20Post&sd=24-bit&sr=1600x1200&vp=1585x1185&je=0&_utma=141232162.675339317.1576772394.1576772394.1576772394.1&_utmz=141232162.1576772394.1.1.utmcsr%3DTAP%2520Evening%2520News%2520Emails%7Cutmccn%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%7Cutmcmd%3DEmail&_utmht=1576772393872&_u=IQBCAUAB~&jid=1342018246&gjid=2096016097&cid=675339317.1576772394&uid=&tid=UA-15871495-32&_gid=1130905905.1576772394&_r=1&gtm=2ouc61&z=223968546

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:814::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:53 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
access-control-allow-origin: *
content-type: image/gif
status: 200
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 35
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 / Show response
googleads.g.doubleclick.net/pagead/viewthroughconversion/995132428/ 3 KB
2 KB 51ms
26ms Script
text/javascript 2a00:1450:4001:817::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/995132428/?random=1576772393920&cv=9&fst=1576772393920&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&gtm=2ouc61&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&tiba=Second%20OS%20Analysis%20of%20First-Line%20Atezolizumab%20Plus%20Nab-paclitaxel%20in%20Advanced%20Triple-Negative%20Breast%20Cancer%20-%20The%20ASCO%20Post&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4

Requested by

Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:817::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

9423f8810fefc7658648974513065c399a73af64a34e493c949055cae002384b

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:53 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-type: text/javascript; charset=UTF-8
server: cafe
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
cache-control: no-cache, must-revalidate
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 1284
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame 71C9 0
0 7ms
7ms Document
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /safeframe/1-0-37/html/container.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
timing-allow-origin: *
content-length: 2973
date: Thu, 19 Dec 2019 15:07:02 GMT
expires: Fri, 18 Dec 2020 15:07:02 GMT
last-modified: Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, immutable, max-age=31536000
age: 4372
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000

GET
H2 200 osd.js Show response
www.googletagservices.com/activeview/js/current/ 78 KB
29 KB 46ms
39ms Script
text/javascript 2a00:1450:4001:809::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

63890326f558587b0840eb0a6e6377f1bf39264e015e568f4c2a03aefce3f929

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:19:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1575654529893506"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 29463
x-xss-protection: 0
expires: Thu, 19 Dec 2019 16:19:54 GMT

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame C24C 0
0 8ms
7ms Document
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /safeframe/1-0-37/html/container.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
timing-allow-origin: *
content-length: 2973
date: Thu, 19 Dec 2019 15:07:02 GMT
expires: Fri, 18 Dec 2020 15:07:02 GMT
last-modified: Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, immutable, max-age=31536000
age: 4372
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame 8CFC 0
0 15ms
9ms Document
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /safeframe/1-0-37/html/container.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
timing-allow-origin: *
content-length: 2973
date: Thu, 19 Dec 2019 15:07:02 GMT
expires: Fri, 18 Dec 2020 15:07:02 GMT
last-modified: Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, immutable, max-age=31536000
age: 4372
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame 39B9 0
0 46ms
0ms Document
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019121002.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /safeframe/1-0-37/html/container.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
timing-allow-origin: *
content-length: 2973
date: Thu, 19 Dec 2019 15:07:02 GMT
expires: Fri, 18 Dec 2020 15:07:02 GMT
last-modified: Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, immutable, max-age=31536000
age: 4372
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000

GET
H2 200 /
www.google.com/pagead/1p-user-list/995132428/ 42 B
525 B 102ms
51ms Image
image/gif 2a00:1450:4001:820::2004
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/pagead/1p-user-list/995132428/?random=1576772393920&cv=9&fst=1576771200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&gtm=2ouc61&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&tiba=Second%20OS%20Analysis%20of%20First-Line%20Atezolizumab%20Plus%20Nab-paclitaxel%20in%20Advanced%20Triple-Negative%20Breast%20Cancer%20-%20The%20ASCO%20Post&async=1&fmt=3&is_vtc=1&random=3458289439&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:54 GMT
x-content-type-options: nosniff
content-type: image/gif
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 /
www.google.de/pagead/1p-user-list/995132428/ 42 B
525 B 90ms
39ms Image
image/gif 2a00:1450:4001:824::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/pagead/1p-user-list/995132428/?random=1576772393920&cv=9&fst=1576771200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=60&u_java=false&u_nplug=0&u_nmime=0&gtm=2ouc61&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&tiba=Second%20OS%20Analysis%20of%20First-Line%20Atezolizumab%20Plus%20Nab-paclitaxel%20in%20Advanced%20Triple-Negative%20Breast%20Cancer%20-%20The%20ASCO%20Post&async=1&fmt=3&is_vtc=1&random=3458289439&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:824::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:54 GMT
x-content-type-options: nosniff
content-type: image/gif
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 204 a
www.googletagmanager.com/ 0
130 B 15ms
13ms Image
image/gif 2a00:1450:4001:81e::2008
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.googletagmanager.com/a?id=GTM-W56397&cv=19&v=3&t=t&pid=462537301&rv=c61&es=1&e=gtm.js&eid=9&tc=19&tr=1cl.1cl.1cl.1cl.1cl.1lcl.1lcl.1lcl.1lcl.1lcl.5cl.5cl.5cl.5cl.5cl.5lcl.5lcl.5lcl.5lcl.5lcl&z=0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:19:54 GMT
server: Google Tag Manager
vary: *
content-type: image/gif
status: 204
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 push
a-84279296.ns8ds.com/web/ 35 B
470 B 595ms
191ms Image
image/gif 54.200.247.129
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://a-84279296.ns8ds.com/web/push?ht=p&o=%7B%22projectId%22%3A%2284279296%22%7D&u=45296800005197&page=%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F&t=1576772408706&sr=%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&rf=&sl=undefined&sp=1&av=5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&l=en-US&pf=Linux%20x86_64&cd=24&h=www.ascopost.com&rs=1600%20x%201200&vis=0&wd=1&pi=0&c=null&bc=v1.001
Requested by: Host: www.ascopost.com
URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.200.247.129 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-200-247-129.us-west-2.compute.amazonaws.com
Software: Gator.IO API /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:20:09 GMT
content-encoding: gzip
server: Gator.IO API
access-control-allow-headers: Accept, Accept-Version, Content-Length, Content-MD5, Content-Type, Date, Api-Version, Response-Time
status: 200
access-control-allow-methods: GET
content-type: image/gif
access-control-allow-origin: *
access-control-expose-headers: Api-Version, Request-Id, Response-Time
cache-control: private, no-cache, no-store, must-revalidate
request-id: 4cd4b6bf-fdc4-4d3b-872b-166a73b39c49
response-time: 0
expires: -1

GET
DATA 200
OK truncated
/ 43 B
0 Image
image/gif

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/gif

GET
H2 200 hotjar-275438.js Show response
static.hotjar.com/c/ 5 KB
3 KB 73ms
25ms Script
application/javascript 147.75.85.25
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL

https://static.hotjar.com/c/hotjar-275438.js?sv=5

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

147.75.85.25 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),

Reverse DNS

pkt-ams-k1-9

Software

openresty /

Resource Hash

074abcafd4c08184eeee02bb4fa0c235598a44a0725ee2592505917aeec740e8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:20:09 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-type: application/javascript
section-io-tag: hotjar
age: 38
status: 200
access-control-max-age: 600
section-io-cache: Hit
content-length: 2279
x-cache-hit: 1
server: openresty
x-frame-options: SAMEORIGIN
etag: W/406d5610c225145cae77ab9c70eadf26
vary: Accept-Encoding
section-io-origin-status: 304
access-control-allow-origin: *
cache-control: max-age=60
section-io-origin-time-seconds: 0.077
accept-ranges: bytes
section-io-id: 7acc984e456f8d8a25d3bdd60a27e0bd

GET
DATA 200
OK truncated
/ 2 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
DATA 200
OK truncated
/ 715 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 _ate.track.config_resp Show response
v1.addthisedge.com/live/boost/ra-5c07fb4043b7033d/ 1 KB
746 B 89ms
40ms Script
application/javascript 23.210.248.44
Akamai Technologies

General

Check archive.org

Show headers Download Go to

Full URL: https://v1.addthisedge.com/live/boost/ra-5c07fb4043b7033d/_ate.track.config_resp
Requested by: Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 23.210.248.44 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS: a23-210-248-44.deploy.static.akamaitechnologies.com
Software: Jetty(9.4.8.v20180619) /
Resource Hash: 9f79817e4b6166c104037ba876a8868ebf72b85926f1ab8fafb4e4f9a7f899ce

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:20:09 GMT
content-encoding: gzip
surrogate-key: ra-5c07fb4043b7033d
server: Jetty(9.4.8.v20180619)
etag: 663301616--gzip
vary: Accept-Encoding
cache-tag: ra-5c07fb4043b7033d
status: 200
cache-control: public, max-age=41, s-maxage=86400
content-disposition: attachment; filename=1.txt
content-type: application/javascript;charset=utf-8
content-length: 502

GET
H2 200 modules.7b8376ee918863f83692.js Show response
script.hotjar.com/ 399 KB
70 KB 85ms
28ms Script
application/javascript 147.75.101.51
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL: https://script.hotjar.com/modules.7b8376ee918863f83692.js
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-275438.js?sv=5
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.101.51 Central, Hong Kong, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS: pkt-ams-k1-7
Software: /
Resource Hash: 65a8e8a1ee215141d2b8377009053f618f941bdb28175fb3ebf4239eed3da8b7

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Dec 2019 16:20:09 GMT
content-encoding: br
content-type: application/javascript
age: 3160
status: 200
section-io-cache: Hit
content-length: 70970
last-modified: Thu, 19 Dec 2019 15:24:18 GMT
etag: "74848e904acdbf63ec8dfb9f3ae6da2d"
vary: Accept-Encoding
section-io-origin-status: 200
access-control-allow-origin: *
cache-control: max-age=31536000
section-io-origin-time-seconds: 0.027
accept-ranges: bytes
section-io-id: 6b24a9edc10e1f332bec94c86a997d31

GET
H2 200 Ahlu Show response
ad.doubleclick.net/ddm/adj/Baaegs/ 11 B
608 B 331ms
32ms Script
text/javascript 216.58.205.230
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://ad.doubleclick.net/ddm/adj/Baaegs/Ahlu

Requested by

Host: niftyhospital.com
URL: https://niftyhospital.com/v2/0/yraDhuW7iybpSh2SzSy4o7-Y3TkogTm6znho_rsVWeuZBkawP2-PZg76oe2LC2HVxqH

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.205.230 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra15s24-in-f230.1e100.net

Software

cafe /

Resource Hash

f1e945400c04241ef089d71de3b0cf7e202431ac4685ada318714fe07ee9dcb0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:20:10 GMT
content-encoding: br
x-content-type-options: nosniff
content-type: text/javascript; charset=UTF-8
server: cafe
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
cache-control: no-cache, must-revalidate
content-disposition: attachment; filename="f.txt"
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 14
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 layers.ab5cd98fe1b9a38a4a9f.js Show response
s7.addthis.com/static/ 263 KB
76 KB 25ms
24ms Script
application/javascript 23.210.248.44
Akamai Technologies

General

Check archive.org

Show headers Download Go to

Full URL

https://s7.addthis.com/static/layers.ab5cd98fe1b9a38a4a9f.js

Requested by

Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

23.210.248.44 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),

Reverse DNS

a23-210-248-44.deploy.static.akamaitechnologies.com

Software

nginx/1.15.8 /

Resource Hash

ecc0c4a707efeb061b7de57440221feb21ab08022938aaacee779e98fe809235

Security Headers

Name	Value
Strict-Transport-Security	max-age=15724800; includeSubDomains

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=15724800; includeSubDomains
content-encoding: gzip
last-modified: Wed, 18 Sep 2019 14:16:17 GMT
server: nginx/1.15.8
etag: W/"5d823c31-41b9f"
vary: Accept-Encoding
content-type: application/javascript
status: 200
cache-control: public, max-age=86313600
date: Thu, 19 Dec 2019 16:20:09 GMT
x-host: s7.addthis.com
timing-allow-origin: *
content-length: 77528

GET
H2 200 box-b736908ce6b0e933fad3a2e45df61b38.html
vars.hotjar.com/ Frame 1BC6 0
0 1110ms
36ms Document
text/html 147.75.84.33
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL: https://vars.hotjar.com/box-b736908ce6b0e933fad3a2e45df61b38.html
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-275438.js?sv=5
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.84.33 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
Software: /
Resource Hash

Request headers

:method: GET
:authority: vars.hotjar.com
:scheme: https
:path: /box-b736908ce6b0e933fad3a2e45df61b38.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
date: Thu, 19 Dec 2019 16:20:11 GMT
content-type: text/html
content-length: 808
last-modified: Tue, 17 Dec 2019 11:49:59 GMT
etag: "ed7551919779fd07dbfe6d776c643379"
cache-control: max-age=31536000
content-encoding: br
section-io-origin-status: 200
section-io-origin-time-seconds: 0.025
age: 102539
vary: Accept-Encoding
section-io-cache: Hit
accept-ranges: bytes
section-io-id: 95f7649a6a1a5d43aba678b98ecb223e

GET
H2 200 / Show response
graph.facebook.com/ 412 B
752 B 56ms
43ms Script
text/javascript 2a03:2880:f01c:800e:face:b00c:0:2
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://graph.facebook.com/?id=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&fields=og_object%7Bengagement%7D&callback=_ate.cbs.rcb_9x7b0

Requested by

Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:800e:face:b00c:0:2 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

946926f1c60c9e7e1a4efbd78af0ef17de78d76e4349dfc121bd374449a40c35

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; preload

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=15552000; preload
content-encoding: br
x-app-usage: {"call_count":0,"total_cputime":0,"total_time":0}
status: 200
date: Thu, 19 Dec 2019 16:20:10 GMT
x-fb-rev: 1001559593
alt-svc: h3-24=":443"; ma=3600
content-length: 280
pragma: no-cache
x-fb-debug: j/WdBRKiJd9n7/qN5tOiTCPZQq+Ovosli9kaGeXNH/S5CqqjbdRX7c4MpJeuP4pE5HitpYBmFI+KK8t87plZfw==
x-fb-trace-id: G6p+2rWleDr
etag: "bc169f09043e93d518911d90b3dc2bf2979465c2"
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
x-fb-request-id: AxgL_HNXDPFoWYtT10GsCh7
cache-control: private, no-cache, no-store, must-revalidate
facebook-api-version: v2.11
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET shares.json
api-public.addthis.com/url/ 0
0

GET
H2 200 / Show response
graph.facebook.com/ 411 B
465 B 36ms
35ms Script
text/javascript 2a03:2880:f01c:800e:face:b00c:0:2
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://graph.facebook.com/?id=http%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&fields=og_object%7Bengagement%7D&callback=_ate.cbs.rcb_k8pu0

Requested by

Host: s7.addthis.com
URL: https://s7.addthis.com/js/300/addthis_widget.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:800e:face:b00c:0:2 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

bdcce9fa79d2fa9304784a554f8f99e41f37c2d9b1bd7b37b7677f3b74f48daa

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000; preload

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=15552000; preload
content-encoding: br
x-app-usage: {"call_count":0,"total_cputime":0,"total_time":0}
status: 200
date: Thu, 19 Dec 2019 16:20:10 GMT
x-fb-rev: 1001559593
alt-svc: h3-24=":443"; ma=3600
content-length: 280
pragma: no-cache
x-fb-debug: xNeGoeXwdW7gMXClAh7cshzoEict/U8O6BDTBPkykxIGhtld6ZFiyOWlnJ1dbaJBoExO76ULgcY1CF9ndo58Cg==
x-fb-trace-id: DKpcEeOfmB5
etag: "7bfedae57e4064eb7ca86bc325799cdbe24a4131"
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
x-fb-request-id: AXsqnlQDCI9A4GPEqZ5Lei4
cache-control: private, no-cache, no-store, must-revalidate
facebook-api-version: v2.11
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET shares.json
api-public.addthis.com/url/ 0
0

GET
DATA 200
OK truncated
/ 443 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 5876d235b697479a9e5f476a33115aea1ddc21fd4b4740dd7180398c6224fdba

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-23/html/ Frame 2BE1 0
0 6ms
6ms Document
text/html 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/safeframe/1-0-23/html/container.html

Requested by

Host: niftyhospital.com
URL: https://niftyhospital.com/v2/0/yraDhuW7iybpSh2SzSy4o7-Y3TkogTm6znho_rsVWeuZBkawP2-PZg76oe2LC2HVxqH

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /safeframe/1-0-23/html/container.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
sec-fetch-mode: nested-navigate
referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
timing-allow-origin: *
content-length: 1479
date: Thu, 05 Dec 2019 17:03:14 GMT
expires: Fri, 04 Dec 2020 17:03:14 GMT
last-modified: Tue, 10 Apr 2018 14:51:09 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, immutable, max-age=31536000
age: 1207016
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000

GET
H2 204 a
www.googletagmanager.com/ 0
56 B 14ms
14ms Image
image/gif 2a00:1450:4001:81e::2008
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.googletagmanager.com/a?id=GTM-W56397&cv=19&v=3&t=t&pid=462537301&rv=c61&es=1&e=gtm.dom&eid=11&tc=19&z=0

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 19 Dec 2019 16:20:10 GMT
server: Google Tag Manager
vary: *
content-type: image/gif
status: 204
cache-control: no-cache, no-store, must-revalidate
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 200 hdgAMedV7AF2N3vJeQ60e2HNkhmwl4y9yMl2GuOP6YfEkVYbX6mVDNkh6xjUwOx-nFxT7vYuwLgEwOO9DUB6otnrulV Show response
coordinatedcoat.com/v2/0/ 216 B
589 B 178ms
29ms Fetch
application/json 35.201.98.64
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://coordinatedcoat.com/v2/0/hdgAMedV7AF2N3vJeQ60e2HNkhmwl4y9yMl2GuOP6YfEkVYbX6mVDNkh6xjUwOx-nFxT7vYuwLgEwOO9DUB6otnrulV

Requested by

Host: niftyhospital.com
URL: https://niftyhospital.com/v2/0/yraDhuW7iybpSh2SzSy4o7-Y3TkogTm6znho_rsVWeuZBkawP2-PZg76oe2LC2HVxqH

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

35.201.98.64 , Ascension Island, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

64.98.201.35.bc.googleusercontent.com

Software

Resource Hash

8241cc9ef67143cb60f7c09361ede5cf4c55e703ca2be17e4e5340d654de1d04

Security Headers

Name	Value
Strict-Transport-Security	max-age=15724800; preload

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
Origin: https://www.ascopost.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15724800; preload
x-datacenter: gce-europe-west1
status: 200
date: Thu, 19 Dec 2019 16:20:14 GMT
vary: Accept-Encoding
access-control-allow-methods: POST, OPTIONS
content-type: application/json; charset=utf-8
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
x-hostname: regan
timing-allow-origin: *
access-control-allow-headers: DNT,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Cookie
content-length: 216
expires: Thu, 19 Dec 2019 16:20:13 GMT

GET
H/1.1 200
OK controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2 Show response
cdn.krxd.net/ctjs/ 248 KB
80 KB 83ms
28ms Script
application/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/controltag/r3w55wq40.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 7daa8dfc1349542ca90836b9becde99fa9bdf0b0599db5513c55ecbe556009a4

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

X-CDN-Backend: 4FrRTvEr9h480D4BywjehZ--F_Controltag_S3
Date: Thu, 19 Dec 2019 16:20:16 GMT
Content-Encoding: gzip
Age: 13402507
X-Cache: HIT
Connection: keep-alive
Content-Length: 81058
X-Served-By: cache-fra19121-FRA
Last-Modified: Tue, 16 Jul 2019 17:45:11 GMT
X-Timer: S1576772417.683274,VS0,VE0
ETag: "05f9d0dad02f8a1b0b028b868bc3a3e2"
Content-Type: application/javascript
Via: 1.1 varnish
Expires: Fri, 13 Jul 2029 17:45:10 GMT
Cache-Control: public, max-age=315360000
Accept-Ranges: bytes
X-Cache-Hits: 4215161

GET
H/1.1 200
OK 6124b294-9e90-4473-8b68-27c76f58648f Show response
consumer.krxd.net/consent/get/ 238 B
615 B 360ms
47ms Script
text/javascript 151.101.112.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://consumer.krxd.net/consent/get/6124b294-9e90-4473-8b68-27c76f58648f?idt=device&dt=kxcookie&callback=Krux.ns.harborside.kxjsonp_consent_get_0
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.112.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 7b3aea2853640282f5bb9e0807549c2fa1838fef7d4ba4fc6c57b6bed0c55a5a

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:17 GMT
Via: 1.1 varnish
Age: 0
X-Timer: S1576772417.188836,VS0,VE26
Vary: Accept-Encoding
X-Cache: MISS, MISS
Content-Type: text/javascript; charset=UTF-8
Cache-Control: max-age=1800
X-Cache-Hits: 0, 0
Connection: keep-alive
Accept-Ranges: bytes
Content-Encoding: gzip
X-Age: 0
Content-Length: 190
X-Served-By: consumer-a011-dub-prod.krxd.net, cache-hhn4063-HHN

GET
H/1.1 200
OK 6124b294-9e90-4473-8b68-27c76f58648f Show response
consumer.krxd.net/consent/set/ 303 B
731 B 388ms
47ms Script
text/javascript 151.101.112.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://consumer.krxd.net/consent/set/6124b294-9e90-4473-8b68-27c76f58648f?idt=device&dt=kxcookie&dc=1&al=1&tg=1&cd=1&sh=1&re=1&callback=Krux.ns.harborside.kxjsonp_consent_set_1
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.112.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: a3d8785d80cfd0818697e90f59983827a655ad3b8597b70d9b5517fcba1a67bf

Request headers

Referer: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Thu, 19 Dec 2019 16:20:17 GMT
Content-Encoding: gzip
Age: 0, 0
X-Timer: S1576772417.236883,VS0,VE26
Vary: Accept-Encoding
X-Cache: MISS, MISS
Content-Type: text/javascript; charset=UTF-8
Via: 1.1 varnish
Cache-Control: private, max-age=10
X-Cache-Hits: 0, 0
Connection: keep-alive
Accept-Ranges: bytes, bytes, bytes
X-Age: 0
Content-Length: 247
X-Served-By: consumer-a009-dub-prod.krxd.net, cache-hhn4063-HHN

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain: api-public.addthis.com
URL: https://api-public.addthis.com/url/shares.json?url=https%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&callback=_ate.cbs.rcb_1ox30

Domain: api-public.addthis.com
URL: https://api-public.addthis.com/url/shares.json?url=http%3A%2F%2Fwww.ascopost.com%2Fnews%2Fdecember-2019%2Fsecond-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer%2F%3Futm_source%3DTAP%2520Evening%2520News%2520Emails%26utm_medium%3DEmail%26utm_campaign%3DTAP%2520Evening%2520News%2520Emails%25209.12.2019%26email%3Dc7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c&callback=_ate.cbs.rcb_4kgn0

Verdicts & Comments Add Verdict or Comment

110 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

0 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

2 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
console-api	log	URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c(Line 159) Message: docType: taparticle
console-api	log	URL: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c(Line 160) Message: page: https://www.ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=c7c22bdc7c1c6e84251a20f9d2f75089fc389cc6e91fc3917ab7608a5f013f0c

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Frame-Options	sameorigin

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a-84279296.cdn.ns8ds.com
a-84279296.ns8ds.com
ad.doubleclick.net
adservice.google.de
api-public.addthis.com
apiservices.krxd.net
cdn.fqtag.com
cdn.krxd.net
code.jquery.com
consumer.krxd.net
coordinatedcoat.com
fonts.googleapis.com
fonts.gstatic.com
fqtag.com
googleads.g.doubleclick.net
graph.facebook.com
hspbotdetection.azurewebsites.net
maxcdn.bootstrapcdn.com
niftyhospital.com
s7.addthis.com
script.hotjar.com
securepubads.g.doubleclick.net
ssl.google-analytics.com
static.hotjar.com
stats.g.doubleclick.net
tpc.googlesyndication.com
v1.addthisedge.com
vars.hotjar.com
www.ascopost.com
www.copyright.com
www.google-analytics.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.googletagservices.com
z.moatads.com
api-public.addthis.com
13.224.196.45
147.75.101.51
147.75.84.33
147.75.85.25
151.101.112.175
151.101.12.175
2001:4de0:ac19::1:b:1a
2001:4de0:ac19::1:b:1b
216.58.205.226
216.58.205.230
216.58.207.66
23.210.248.44
23.210.250.213
2a00:1450:4001:806::2001
2a00:1450:4001:808::2002
2a00:1450:4001:809::2002
2a00:1450:4001:809::200a
2a00:1450:4001:80b::2008
2a00:1450:4001:814::200e
2a00:1450:4001:816::2003
2a00:1450:4001:817::2002
2a00:1450:4001:818::2008
2a00:1450:4001:819::2002
2a00:1450:4001:81e::2008
2a00:1450:4001:820::2004
2a00:1450:4001:824::2003
2a00:1450:400c:c00::9d
2a03:2880:f01c:800e:face:b00c:0:2
35.190.36.172
35.190.72.161
35.190.74.157
35.201.98.64
52.173.245.249
52.206.22.209
54.200.247.129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www.ascopost.com Open in urlscan Pro 52.173.245.249 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page URL History Show full URLs

Detected technologies

Page Statistics

87 Requests

98 %HTTPS

49 %IPv6

25 Domains

37 Subdomains

35 IPs

7 Countries

1006 kBTransfer

2848 kBSize

0 Cookies

10 Outgoing links

Page URL History

Redirected requests

87 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 4 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

www.ascopost.com Open in urlscan Pro
52.173.245.249 Public Scan

Screenshot
Live screenshot

Full Image

87
Requests

98 %
HTTPS

49 %
IPv6

25
Domains

37
Subdomains

35
IPs

7
Countries

1006 kB
Transfer

2848 kB
Size

0
Cookies

87 HTTP transactions
4 data transactions